# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001847903-26-000040
Filing Date
2026-04-29
Accepted
2026-04-29 08:00:29
Documents
17
Period of Report
2026-06-12

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | cnta-20260428.htm iXBRL | DEF 14A | 870361
3 |  | cnta-20260428_g1.jpg | GRAPHIC | 10045
4 |  | cnta-20260428_g2.jpg | GRAPHIC | 90639
5 |  | cnta-20260428_g3.jpg | GRAPHIC | 109228
6 |  | cnta-20260428_g4.jpg | GRAPHIC | 86454
7 |  | cnta-20260428_g5.jpg | GRAPHIC | 219128
8 |  | cnta-20260428_g6.jpg | GRAPHIC | 175512
| Complete submission text file | 0001847903-26-000040.txt |  | 2885519

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | cnta-20260428.xsd | EX-101.SCH | 916
20 | EXTRACTED XBRL INSTANCE DOCUMENT | cnta-20260428_htm.xml | XML | 2865

Mailing Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT
Business Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT 44 7391 789784
Centessa Pharmaceuticals plc (Filer) CIK: 0001847903 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40445 | Film No.: 26910612
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)